The Department of Education (DepEd) remains steadfast in promoting transparency, integrity, and accountability by making basic education data accessible to the public which empowers internal and ...

The Nike Mind shoes have foam nodes on the bottom of the shoe to help activate key pressure points in the brain. Nike Mind pregame mules are $95 while shoes are $145. Whether you're training or in ...

Nike’s new Mind Technology might have been launched in a pre-game slide, but now the everyday sneaker seekers can sport the invention, too. Connect with your surroundings everywhere you go. Stay ...

Nike Mind 001 and 002: The Fit A lot of what I’ve already read or seen online is that both the 001 and the 002 fit a bit snug, and that you should size up. Since they only come in full sizes, I wouldn ...

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS ~ Designation enables an enhanced development ...

In a phase 2 trial, intravesical TARA-002 showed a 72% complete response rate at any time among patients with high-grade NMIBC naïve to BCG. The investigational intravesical cell therapy TARA-002 ...

The core of the technology lies in the shoe’s sole: 22 independent foam nodes per shoe are strategically mapped to stimulate key sensory receptors underfoot. This process amplifies ground sensation, ...

TARA-002 demonstrates high complete response rates in BCG-naïve NMIBC patients, with 72% achieving CR and 50% maintaining it at 12 months. The treatment involves six weekly bladder instillations, ...

Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase 3-ready eye disease drug. The asset in question is ILYX-002, a topical ...

Vectory Therapeutics BV has obtained IND clearance from the FDA for a phase I/II trial (PIONEER-ALS) of VTX-002, a first-in-class vectorized antibody targeting TDP-43 pathology in amyotrophic lateral ...